Ben Enejo
Partner
Ben assists top healthcare clients across Regulatory & Medical Affairs functions, as well as Commercial Strategy & Operations, with a specialty in business transformation and operational excellence initiatives.
![Ben Enejo | ADLITTLE](/sites/default/files/styles/management_team_person_image_m/public/team_management/BEN_ENEJO.png,qitok=XC16KDYD.pagespeed.ce.sTwop7shdl.png)
Areas of Focus
Education
Past Experience
![Ben Enejo | ADLITTLE](/sites/default/files/styles/management_team_person_image_m/public/team_management/BEN_ENEJO.png,qitok=XC16KDYD.pagespeed.ce.sTwop7shdl.png)
Ben is a Partner at Arthur D. Little, based in our Boston office, and a member of our global Healthcare & Life Sciences Practice.
Ben is an experienced management consultant and industry expert having worked with various global biopharmaceutical companies on strategies to accelerate the development of new medicines through to commercialization. Particular areas of expertise include clinical trial acceleration, R&D transformation including advanced technology application, increasing success for rare disease drug development and launch, patient and drug safety, and quality and compliance excellence.
Ben holds an MBA with other qualifications in Molecular Medicine, Pharmacology and Physiology, and Program management.
![Accelerating cures](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_Accelerating,P20cures_image_600x375.jpg,qitok=mJJnbWJm.pagespeed.ce.g_brUE9rUs.jpg)
Accelerating cures
![Why patient centricity is key to long-term pharma company success](/sites/default/files/styles/management_insights_m/public/prism/ADL_Patient_header_image_1605x662.jpg,qitok=s8NbdAeS.pagespeed.ce.q7lNnjmhCN.jpg)
Why patient centricity is key to long-term pharma company success
![The future of pharmacovigilance](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_PublicationName_image_600x375_0.jpg?itok=vYCo6twz)
The future of pharmacovigilance
![](/sites/default/files/styles/management_insights_m/public/reports/Elixir_Image.jpg,qitok=gYYwQIho.pagespeed.ce.HEzVGSuoZR.jpg)
![](/sites/default/files/styles/management_insights_m/public/viewpoints/cart_t_cover.jpg?itok=PErW7_ij)
CAR-T on site: Forgoing the extra mile
![](/sites/default/files/styles/management_insights_m/public/viewpoints/adl_managing_clinical_trials_cover_0.jpg?itok=Zqc-zu-l)
Managing clinical trials during COVID-19 and beyond
![](/sites/default/files/styles/management_insights_m/public/reports/gettyimages-916075464-min.jpg?itok=OMy-XZ5L)
![](/sites/default/files/styles/management_insights_m/public/reports/gettyimages-617393968-min.jpg?itok=l--3ikzn)
Maximizing the rare chance of launch success with orphan drugs
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-157671583_sailing_reduced-min.jpg?itok=Tye7LJfp)
The BIG patent expiry question: Why sink when you can sail?
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-182151903_medicine_tablets_reduced.jpg?itok=0ZuZ0SmG)
Pharmacovigilance literature review in the age of precision medicine
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-928265932.jpg?itok=AHPEb0CG)
Finding the needle in the PV haystack
![Ben Enejo | ADLITTLE](/sites/default/files/styles/management_team_person_image_m/public/team_management/BEN_ENEJO.png,qitok=XC16KDYD.pagespeed.ce.sTwop7shdl.png)
Ben is a Partner at Arthur D. Little, based in our Boston office, and a member of our global Healthcare & Life Sciences Practice.
Ben is an experienced management consultant and industry expert having worked with various global biopharmaceutical companies on strategies to accelerate the development of new medicines through to commercialization. Particular areas of expertise include clinical trial acceleration, R&D transformation including advanced technology application, increasing success for rare disease drug development and launch, patient and drug safety, and quality and compliance excellence.
Ben holds an MBA with other qualifications in Molecular Medicine, Pharmacology and Physiology, and Program management.
![Accelerating cures](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_Accelerating,P20cures_image_600x375.jpg,qitok=mJJnbWJm.pagespeed.ce.g_brUE9rUs.jpg)
Accelerating cures
![Why patient centricity is key to long-term pharma company success](/sites/default/files/styles/management_insights_m/public/prism/ADL_Patient_header_image_1605x662.jpg,qitok=s8NbdAeS.pagespeed.ce.q7lNnjmhCN.jpg)
Why patient centricity is key to long-term pharma company success
![The future of pharmacovigilance](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_PublicationName_image_600x375_0.jpg?itok=vYCo6twz)
The future of pharmacovigilance
![](/sites/default/files/styles/management_insights_m/public/reports/Elixir_Image.jpg,qitok=gYYwQIho.pagespeed.ce.HEzVGSuoZR.jpg)
![](/sites/default/files/styles/management_insights_m/public/viewpoints/cart_t_cover.jpg?itok=PErW7_ij)
CAR-T on site: Forgoing the extra mile
![](/sites/default/files/styles/management_insights_m/public/viewpoints/adl_managing_clinical_trials_cover_0.jpg?itok=Zqc-zu-l)
Managing clinical trials during COVID-19 and beyond
![](/sites/default/files/styles/management_insights_m/public/reports/gettyimages-916075464-min.jpg?itok=OMy-XZ5L)
![](/sites/default/files/styles/management_insights_m/public/reports/gettyimages-617393968-min.jpg?itok=l--3ikzn)
Maximizing the rare chance of launch success with orphan drugs
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-157671583_sailing_reduced-min.jpg?itok=Tye7LJfp)
The BIG patent expiry question: Why sink when you can sail?
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-182151903_medicine_tablets_reduced.jpg?itok=0ZuZ0SmG)
Pharmacovigilance literature review in the age of precision medicine
![](/sites/default/files/styles/management_insights_m/public/viewpoints/gettyimages-928265932.jpg?itok=AHPEb0CG)
Finding the needle in the PV haystack
More About Ben
- Cranfield School of ManagementMaster of Business Administration
- Cranfield UniversityM.Sc. Molecular Medicine
- Nottingham Trent UniversityB.Sc. Physiology & Pharmacology
- PA Consulting GroupHealthcare Management Consultant
- Astra ZenecaPatient Safety Advisor
- Janssen Pharmaceuticals (Johnson & Johnson)Pharmacovigilance Associate
- Medical Gases LtdSales Engineer (Business Development)